On December 3, 2025, Charles River Laboratories presented at Evercore’s 8th Annual Healthcare Conference in Coral Gables, highlighting fourth-quarter demand trends and improving Discovery and Safety ...
– Jim Foster, Chair, President & CEO, Announces Plans to Retire at the 2026 Annual Meeting of Shareholders in May 2026 After Distinguished 50-Year Career at Charles River – – Birgit Girshick, Current ...
Charles River Laboratories has had an impressive run over the past six months as its shares have beaten the S&P 500 by 20.5%. The stock now trades at $189.18, marking a 27% gain. This was partly ...
– Signs Agreement to Acquire K.F. (Cambodia) Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in 2026 and ...
– Providing Update on Recent Business Trends and Preliminary 2026 Outlook at J.P. Morgan Healthcare Conference – The proposed acquisition of PathoQuest will strengthen Charles River’s existing ...
Kerry Dailey Will Join Charles River as Corporate Senior Vice President and Chief Legal Officer WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する